January 23 – 25,
January 29 - 31,2020PRAGUE



Andrea Camerini, MD, PhD
Hospital of Versilia (Italy), Department of Medical Oncology

Prof. Dr. Magdolna Dank
Director, Cancer Center of Semmelweis University, Budapest

Alessandra Gennari, MD, PhD
Associate professor of Oncology; Director, Division of Oncology Department of Translational Medicine, University of Piemonte Orientale

Axel Grothey, MD
Consultant, West Cancer Center, University of Tennessee, in Memphis, TN

Dr. Filip Janku, MD, PhD
Associate professor, the Department of Investigational Cancer Therapeutics (Phase I Program); Center Medical Director, Clinical and Translational Research Center at The University of Texas MD Anderson Cancer Center

Prof. Dr. med. Sibylle Loibl
Chief executive officer, GBG Forschungs GmbH; Chair, German Breast Group (study group)

Prof. Dr. med Florian Lordick
University Cancer Centre Leipzig; Department of Hematology and Cell Therapy, Medical Oncology and Hemostaseology of the University Medicine Leipzig

Jolanta Małyszko, prof. dr hab.
Medical University of Warsaw, Nephrology, Dialysis and Internal Medicine, Poland

Dr. Catherine Alix-Panabières, PhD
University Medical Center of Montpellier; Hospital of Montpellier; the Faculty of Medicine of Montpellier (MCU-PH)

Prof. Marc Peeters, MD, PhD
Professor of oncology, Antwerp University, Belgium

Prof. Nir Peled, MD, PhD, FCCP
Expert in internal medicine, pulmonology and medical oncology, Herzliya Medical Center, St. Herzliya, Israel

Univ. Prof. Mag. Dr. Robert Pirker
Department of medicine I, Medical University of Vienna, Vienna, Austria

Assoc. Prof. Priv. Doz. Dr. Gerald Prager
Specialist in hematology, internal oncology and internal medicine

Timothy Yap, MBBS, Ph.D., MRCP(UK), BSc (Hons), PgDip
Department of Investigational Cancer Therapeutics, Division of Cancer Medicine Division